Astellas Pharma Financial Overview
Astellas Pharma's market cap is currently ¥3.80T. The company's EPS TTM is ¥44.22; its P/E ratio is 30.26; and it has a dividend yield of 3.60%. Astellas Pharma is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is ¥43.03. See an overview of income statement, balance sheet, and cash flow financials.
